Related Experiment Video

Updated: Sep 15, 2025

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

12.9K

Debates in Management and Treatment of CMV in Pediatric Solid Organ Transplant Recipients: A Case-Based Discussion

Kevin J Downes1,2, Lara Danziger-Isakov3, Gustavo Varela-Fascinetto4

  • 1Department of Pediatrics, Perelman School at Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Pediatric Transplantation
|July 17, 2025
PubMed

Insights

The 4th International Consensus Guidelines offer updated recommendations for cytomegalovirus (CMV) management in pediatric solid organ transplant (pSOT) recipients. This report addresses knowledge gaps and controversial areas needing further research in pSOT care.

Area of Science:

  • Transplant medicine
  • Infectious diseases
  • Pediatric critical care

Background:

  • Cytomegalovirus (CMV) poses significant risks in pediatric solid organ transplantation (pSOT).
  • The 4th International Consensus Guidelines provide updated recommendations for CMV management in pSOT.
  • Existing guidelines face challenges due to limited pediatric-specific data and divergent findings.

Purpose of the Study:

  • To highlight controversial and unresolved issues in CMV management for pSOT recipients.
  • To provide rationale for expert opinions on complex management scenarios.
  • To identify critical areas requiring further research in pediatric CMV care.

Main Methods:

  • Review of current literature and the 4th International Consensus Guidelines.
  • Case-based approach to illustrate controversial management areas.
  • Expert opinion synthesis on pediatric-specific challenges.

Main Results:

  • Identified significant knowledge gaps in pediatric CMV prevention, treatment, and monitoring.
  • Highlighted discrepancies between pediatric and adult data, necessitating tailored approaches.
  • Emphasized the need for evidence-based strategies for pSOT patients.

Conclusions:

  • Further research is crucial to address the paucity of pediatric data in CMV management.
  • Expert consensus and case discussions are vital for navigating complex pSOT scenarios.
  • Tailored guidelines are needed to optimize CMV outcomes in pediatric solid organ transplant recipients.

More Related Videos

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates05:53

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates

Published on: July 6, 2013

15.1K
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.3K

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
83
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
227
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
64
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.2K
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
524
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
502